2 completed, 2 unknown, 1 terminated. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Unknown 2, Terminated 1 |
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study Ad26.ZEBOV, MVA-BN-Filo - Virus Diseases, Hemorrhagic Fever, Ebola | Phase 2 | Completed | London School of Hygiene and Tropical Medicine | 133 | 2022-09-19 | 2025-05-11 |
| Propranolol on Post Stroke Immune Status and Infection Propranolol, Ceftriaxone - Stroke, Cerebrovascular Disorders | Phase 2 | Unknown | Tianjin Medical University General Hospital | 45 | 2022-06-01 | 2022-05-16 |
| Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. Subunit recombinant vaccine for the prevention of coronavirus infection, Placebo - COVID-19, Immunologic Factors | Phase 1 / Phase 2 | Completed | St. Petersburg Research Institute of Vaccines and Sera | 155 | 2021-07-19 | 2023-08-30 |
| Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12, Temozolomide - Glioblastoma, Glioma | Phase 1 / Phase 2 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 10 | 2020-12-01 | 2020-06-09 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 CYNK-001 - Coronavirus, Coronavirus Infection | Phase 1 / Phase 2 | Terminated | Celularity Incorporated | 7 | 2020-09-02 | 2026-06-26 |
COVID-19 (2) · Coronavirus Infections (2) · Infections (2) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Coronaviridae Infections (1) · Filoviridae Infections (1) · Glioblastoma (1) · Glioma (1) · Hemorrhagic Fever, Ebola (1)
Infections (2) · Astrocytoma (1) · Coronaviridae Infections (1) · Lung Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Vascular Diseases (1) · Virus Diseases (1)
Ceftriaxone (1) · Interleukin-12 (1) · Propranolol (1) · Temozolomide (1)
Celularity Incorporated (1) · London School of Hygiene and Tropical Medicine (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · St. Petersburg Research Institute of Vaccines and Sera (1) · Tianjin Medical University General Hospital (1)
China (2) · Russia (1) · Sierra Leone (1) · United States (1)
Corey Casper, MD MPH (1) · Deborah Watson-Jones, PhD (1) · Hong Shen, MD (1)